• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » DNAnexus, Solvebio partner to make genomic data more actionable

DNAnexus, Solvebio partner to make genomic data more actionable

April 21, 2016
CenterWatch Staff

DNAnexus, a cloud-based genome informatics and data management provider, has announced a partnership with SolveBio, a global provider of Genomics Intelligence, to integrate the two platforms and provide seamless access to SolveBio’s curated data and analysis services. Researchers globally will have the ability to move quickly from genomic data analysis to interpretation, freeing up time to focus on generating uniquely actionable biological insights.

DNAnexus combines expertise in cloud computing and bioinformatics to provide the global network for organizations that are pursuing genomic-based approaches to health, in the clinic and in the research lab. DNAnexus provides pharmaceutical and biotech companies, global diagnostic test providers, genome centers and sequencing service providers the infrastructure and scientific support to solve today’s genomic challenges faster and more effectively than ever before.

“Both DNAnexus and SolveBio make genomic data more accessible, easier to analyze and more actionable,” said Richard Daly, CEO of DNAnexus. “We view the integration of DNAnexus’ and SolveBio’s complementary product offerings as a way help to remove barriers to genomic insight and provide better solutions to enterprises globally.”

SolveBio gathers, secures and monitors real-time genomics intelligence for the pharmaceutical and global diagnostic markets. Access to the latest discoveries and expert assessments in genomics guides key investment decisions in R&D and treatment plans in the clinic. SolveBio turns evaluating and using internal and external insights and information into a standardized task-oriented process for scientists, clinicians and directors. Integrating with genomic analysis companies allows enterprises leveraging genomics to bring Genomics Intelligence into any workflow or pipeline in a standardized process.

“Our passion is to help scientists make sense of complexity and to use that intelligence to drive issues around human health,” said Mark Kaganovich, CEO of SolveBio. “Our goals are aligned with those of DNAnexus and an integration between our solutions makes a great deal of sense. We look forward to our collective customers being able to seamlessly integrate their analyses with the contextual information that SolveBio provides.”

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • SurveywBlueBackground-360x240.png

    Sites Name Tech Acceptance as Essential Factor in Selection of Sponsors, Survey Finds

  • TrendsInsights2023-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Two

  • TimeMoneyEffort-360x240.png

    Time is Money and So Is Effort, Budgeting Experts Say

  • TrendsInsights2023A-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Three

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing